{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:10:31Z","timestamp":1793139031415,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180886"],"award-info":[{"award-number":["U10CA180886"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R35CA220502"],"award-info":[{"award-number":["R35CA220502"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation","doi-asserted-by":"crossref","award":["DT2019-010"],"award-info":[{"award-number":["DT2019-010"]}],"id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100017012","name":"Children\u2019s Oncology Group","doi-asserted-by":"publisher","award":["COG-ALTE03N1"],"award-info":[{"award-number":["COG-ALTE03N1"]}],"id":[{"id":"10.13039\/100017012","id-type":"DOI","asserted-by":"publisher"}]},{"name":"St. Baldrick\u2019s Foundation"},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["6563-19"],"award-info":[{"award-number":["6563-19"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Anthracycline-induced cardiomyopathy is a leading cause of morbidity and mortality in survivors of childhood cancer. The mitochondrion is a key mediator of the cytotoxic effects of anthracycline treatment and mitochondrial dysfunction is a hallmark of cardiomyopathy and heart failure. We sought to evaluate whether mitochondrial processes differ between anthracycline-exposed childhood cancer survivors who developed cardiomyopathy versus those who did not.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Peripheral blood was collected from 40 childhood cancer survivors who developed cardiomyopathy (cases) and 64 matched survivors who did not (controls). From these samples, gene expression was determined by RNA-Sequencing. Following bioinformatic processing, differential gene expression at the mRNA-level between cases and controls was determined. Human MitoCarta3.0, was utilized to determine if genes involved in mitochondrial processes were enriched for differential expression, and to identify differentially regulated mitochondrial pathways at the mRNA-level.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>900 genes were identified as differentially expressed at the mRNA-level. The odds of a gene being differentially expressed were 2.43 times greater if it encodes for a protein that localizes to the mitochondria. Mitochondrial processes that were enriched for differentially expressed genes at the mRNA-level included electron transport chain complexes; reactive oxygen species metabolism; apoptosis, mitophagy, and autophagy; mitochondrial ribosome; mitochondrial transport and chaperones; and heme synthesis and processing. Additionally, we observed that a measure of pro-apoptotic balance (BAX to BCL-2 gene expression at the mRNA-level) was highest in severe cardiomyopathy, intermediate in mild cardiomyopathy, and lowest in survivors without cardiomyopathy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We observed substantial evidence that the expression of genes involved in mitochondrial processes differs in childhood cancer survivors who develop cardiomyopathy versus those who do not.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40959-025-00391-w","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T14:03:05Z","timestamp":1759759385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anthracycline-induced cardiomyopathy in childhood cancer survivors is associated with gene signatures of mitochondrial dysfunction\u2014a COG ALTE03N1 report"],"prefix":"10.1186","volume":"11","author":[{"given":"Patrick J.","family":"Trainor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purnima","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Sharafeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Hageman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saro H.","family":"Armenian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P.","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank G.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Neglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Landier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"issue":"4","key":"391_CR1","first-page":"539","volume":"2","author":"S Bhatia","year":"2020","unstructured":"Bhatia S. Genetics of anthracycline cardiomyopathy in cancer survivors. JACC: CardioOncology. 2020;2(4):539\u201352.","journal-title":"JACC: CardioOncology"},{"issue":"2","key":"391_CR2","doi-asserted-by":"publisher","first-page":"e2254669","DOI":"10.1001\/jamanetworkopen.2022.54669","volume":"6","author":"CM Larsen","year":"2023","unstructured":"Larsen CM, Garcia Arango M, Dasari H, Arciniegas Calle M, Adjei E, Rico Mesa J, et al. Association of anthracycline with heart failure in patients treated for breast cancer or Lymphoma, 1985\u20132010. JAMA Netw Open. 2023;6(2):e2254669.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"391_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/hrt.2007.136093","volume":"94","author":"SE Lipshultz","year":"2007","unstructured":"Lipshultz SE, Alvarez JA, Scully RE. Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart. 2007;94(4):525\u201333.","journal-title":"Heart"},{"issue":"15","key":"391_CR4","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","volume":"342","author":"GM Felker","year":"2000","unstructured":"Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and Long-Term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342(15):1077\u201384.","journal-title":"N Engl J Med"},{"issue":"2","key":"391_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1172\/JCI72931","volume":"124","author":"Y Ichikawa","year":"2014","unstructured":"Ichikawa Y, Ghanefar M, Bayeva M, Wu R, Khechaduri A, Prasad SVN, et al. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J Clin Invest. 2014;124(2):617\u201330.","journal-title":"J Clin Invest"},{"issue":"2","key":"391_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1124\/mol.105.013383","volume":"68","author":"X Xu","year":"2005","unstructured":"Xu X, Persson HL, Richardson DR. Molecular Pharmacology of the interaction of anthracyclines with iron. Mol Pharmacol. 2005;68(2):261\u201371.","journal-title":"Mol Pharmacol"},{"issue":"11","key":"391_CR7","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","volume":"18","author":"S Zhang","year":"2012","unstructured":"Zhang S, Liu X, Bawa-Khalfe T, Lu L-S, Lyu YL, Liu LF, et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med. 2012;18(11):1639\u201342.","journal-title":"Nat Med"},{"issue":"1","key":"391_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10565-006-0140-y","volume":"23","author":"JM Berthiaume","year":"2006","unstructured":"Berthiaume JM, Wallace KB. Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol Toxicol. 2006;23(1):15\u201325.","journal-title":"Cell Biol Toxicol"},{"key":"391_CR9","doi-asserted-by":"crossref","unstructured":"Mordente A, Meucci E, Silvestrini A, Martorana GE, Giardina B. Anthracyclines and Mitochondria. Advances in mitochondrial medicine. Advances in experimental medicine and Biology2012. pp. 385\u2013419.","DOI":"10.1007\/978-94-007-2869-1_18"},{"issue":"1","key":"391_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/scientificamerican0757-131","volume":"197","author":"P Siekevitz","year":"1957","unstructured":"Siekevitz P. Powerhouse of the cell. Sci Am. 1957;197(1):131\u201344.","journal-title":"Sci Am"},{"issue":"36","key":"391_CR11","doi-asserted-by":"publisher","first-page":"7771","DOI":"10.1523\/JNEUROSCI.1842-04.2004","volume":"24","author":"L Tretter","year":"2004","unstructured":"Tretter L, Adam-Vizi V. Generation of reactive oxygen species in the reaction catalyzed by \u03b1-Ketoglutarate dehydrogenase. J Neurosci. 2004;24(36):7771\u20138.","journal-title":"J Neurosci"},{"key":"391_CR12","doi-asserted-by":"crossref","unstructured":"Lenaz G. Mitochondria and reactive oxygen Species. Which role in physiology and pathology? Advances in mitochondrial medicine. Advances in experimental medicine and biology2012. pp. 93\u2013136.","DOI":"10.1007\/978-94-007-2869-1_5"},{"issue":"3","key":"391_CR13","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.cell.2015.10.001","volume":"163","author":"S Shadel Gerald","year":"2015","unstructured":"Shadel Gerald S, Horvath Tamas L. Mitochondrial ROS signaling in organismal homeostasis. Cell. 2015;163(3):560\u20139.","journal-title":"Cell"},{"key":"391_CR14","doi-asserted-by":"crossref","unstructured":"Scatena R. Mitochondria and cancer: A growing role in Apoptosis, cancer cell metabolism and Dedifferentiation. Advances in mitochondrial medicine. Advances in experimental medicine and Biology2012. pp. 287\u2013308.","DOI":"10.1007\/978-94-007-2869-1_13"},{"issue":"5","key":"391_CR15","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s10495-007-0756-2","volume":"12","author":"M Ott","year":"2007","unstructured":"Ott M, Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis. 2007;12(5):913\u201322.","journal-title":"Apoptosis"},{"issue":"9","key":"391_CR16","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1172\/JCI120849","volume":"128","author":"B Zhou","year":"2018","unstructured":"Zhou B, Tian R. Mitochondrial dysfunction in pathophysiology of heart failure. J Clin Invest. 2018;128(9):3716\u201326.","journal-title":"J Clin Invest"},{"issue":"12","key":"391_CR17","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1161\/RES.0000000000000104","volume":"118","author":"E Murphy","year":"2016","unstructured":"Murphy E, Ardehali H, Balaban RS, DiLisa F, Dorn GW, Kitsis RN, et al. Mitochondrial Function, Biology, and role in disease. Circul Res. 2016;118(12):1960\u201391.","journal-title":"Circul Res"},{"issue":"2","key":"391_CR18","doi-asserted-by":"publisher","first-page":"H742","DOI":"10.1152\/ajpheart.1994.267.2.H742","volume":"267","author":"MF Allard","year":"1994","unstructured":"Allard MF, Schonekess BO, Henning SL, English DR, Lopaschuk GD. Contribution of oxidative metabolism and Glycolysis to ATP production in hypertrophied hearts. Am J Physiol Heart Circ Physiol. 1994;267(2):H742\u201350.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"391_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1023\/A:1015380609464","volume":"7","author":"N Sambandam","year":"2002","unstructured":"Sambandam N, Lopaschuk GD, Brownsey RW, Allard MF. Energy metabolism in the hypertrophied heart. Heart Fail Rev. 2002;7(2):161\u201373.","journal-title":"Heart Fail Rev"},{"issue":"5","key":"391_CR20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/life11050436","volume":"11","author":"G Morciano","year":"2021","unstructured":"Morciano G, Vitto VAM, Bouhamida E, Giorgi C, Pinton P. Mitochondrial bioenergetics and dynamism in the failing heart. Life. 2021;11(5):436.","journal-title":"Life"},{"key":"391_CR21","doi-asserted-by":"crossref","unstructured":"Singh P, Shah DA, Jouni M, Cejas RB, Crossman DK, Magdy T et al. Altered peripheral blood gene expression in childhood cancer survivors with Anthracycline-Induced Cardiomyopathy \u2013 A COG\u2010ALTE03N1 report. J Am Heart Association. 2023;12(19).","DOI":"10.1161\/JAHA.123.029954"},{"issue":"14","key":"391_CR22","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies. Circulation. 2006;113(14):1807\u201316.","journal-title":"Circulation"},{"issue":"6","key":"391_CR23","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1001\/jamaoncol.2018.6634","volume":"5","author":"EAM Feijen","year":"2019","unstructured":"Feijen EAM, Leisenring WM, Stratton KL, Ness KK, van der Pal HJH, van Dalen EC, et al. Derivation of anthracycline and anthraquinone equivalence ratios to doxorubicin for Late-Onset cardiotoxicity. JAMA Oncol. 2019;5(6):864\u201371.","journal-title":"JAMA Oncol"},{"issue":"12","key":"391_CR24","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"D1","key":"391_CR25","doi-asserted-by":"publisher","first-page":"D1541","DOI":"10.1093\/nar\/gkaa1011","volume":"49","author":"S Rath","year":"2021","unstructured":"Rath S, Sharma R, Gupta R, Ast T, Chan C, Durham TJ, et al. MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. 2021;49(D1):D1541\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"391_CR26","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1073\/pnas.242716699","volume":"100","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lepage P, Miller K, Bunkenborg J, Reich M, Hjerrild M, et al. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci U S A. 2003;100(2):605\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"391_CR27","first-page":"1","volume":"60012","author":"G Korotkevich","year":"2021","unstructured":"Korotkevich G, Sukhov V, Budin N, Shpak B, Artyomov MN, Sergushichev A. Fast gene set enrichment analysis. BioRxiv. 2021;60012:1\u201334.","journal-title":"BioRxiv"},{"issue":"1","key":"391_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol). 1995;57(1):289\u2013300.","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"issue":"2","key":"391_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1046\/j.0022-202x.2001.01409.x","volume":"117","author":"M Raisova","year":"2001","unstructured":"Raisova M, Hossini AM, Eberle J, Riebeling C, Orfanos CE, Geilen CC, et al. The Bax\/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95\/Fas-Mediated apoptosis. J Invest Dermatology. 2001;117(2):333\u201340.","journal-title":"J Invest Dermatology"},{"issue":"1","key":"391_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3324\/haematol.2015.131854","volume":"101","author":"MI Del Principe","year":"2015","unstructured":"Del Principe MI, Bo MD, Bittolo T, Buccisano F, Rossi FM, Zucchetto A, et al. Clinical significance of bax\/bcl-2 ratio in chronic lymphocytic leukemia. Haematologica. 2015;101(1):77\u201385.","journal-title":"Haematologica"},{"issue":"6","key":"391_CR31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/oxfordjournals.eurheartj.a059743","volume":"11","author":"A Buchwald","year":"1990","unstructured":"Buchwald A, Till H, Unterberg C, Oberschmidt R, Figulla HR, Wiegand V. Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy. Eur Heart J. 1990;11(6):509\u201316.","journal-title":"Eur Heart J"},{"issue":"4","key":"391_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/1071-9164(95)90003-9","volume":"1","author":"J Marin-Garcia","year":"1995","unstructured":"Marin-Garcia J, Goldenthal MJ, Pierpont MEM, Ananthakrishnan R. Impaired mitochondrial function in idiopathic dilated cardiomyopathy: biochemical and molecular analysis. J Card Fail. 1995;1(4):285\u201391.","journal-title":"J Card Fail"},{"issue":"12","key":"391_CR33","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0300-8932(02)76802-4","volume":"55","author":"J Mar\u00edn-Garc\u00eda","year":"2002","unstructured":"Mar\u00edn-Garc\u00eda J, Goldenthal MJ. The mitochondrial organelle and the heart. Rev Esp Cardiol. 2002;55(12):1293\u2013310.","journal-title":"Rev Esp Cardiol"},{"issue":"1","key":"391_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15171\/jcvtr.2018.01","volume":"10","author":"SH Hassanpour","year":"2018","unstructured":"Hassanpour SH, Dehghani MA, Karami SZ. Study of respiratory chain dysfunction in heart disease. J Cardiovasc Thorac Res. 2018;10(1):1\u201313.","journal-title":"J Cardiovasc Thorac Res"},{"issue":"2","key":"391_CR35","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/cvr\/cvn098","volume":"79","author":"R Ventura-Clapier","year":"2008","unstructured":"Ventura-Clapier R, Garnier A, Veksler V. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1. Cardiovascular Res. 2008;79(2):208\u201317.","journal-title":"Cardiovascular Res"},{"issue":"3","key":"391_CR36","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.molcel.2011.11.027","volume":"45","author":"M Day Alison","year":"2012","unstructured":"Day Alison M, Brown Jonathon D, Taylor Sarah R, Rand Jonathan D, Morgan Brian A, Veal Elizabeth A. Inactivation of a Peroxiredoxin by hydrogen peroxide is critical for Thioredoxin-Mediated repair of oxidized proteins and cell survival. Mol Cell. 2012;45(3):398\u2013408.","journal-title":"Mol Cell"},{"issue":"2","key":"391_CR37","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.bbrc.2007.02.018","volume":"355","author":"A Siritantikorn","year":"2007","unstructured":"Siritantikorn A, Johansson K, \u00c5hlen K, Rinaldi R, Suthiphongchai T, Wilairat P, et al. Protection of cells from oxidative stress by microsomal glutathione transferase 1. Biochem Biophys Res Commun. 2007;355(2):592\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"391_CR38","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.freeradbiomed.2009.05.018","volume":"47","author":"L Miao","year":"2009","unstructured":"Miao L, St. Clair DK. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med. 2009;47(4):344\u201356.","journal-title":"Free Radic Biol Med"},{"issue":"41","key":"391_CR39","doi-asserted-by":"publisher","first-page":"38084","DOI":"10.1074\/jbc.M105296200","volume":"276","author":"LA Sturtz","year":"2001","unstructured":"Sturtz LA, Diekert K, Jensen LT, Lill R, Culotta VC. A fraction of yeast Cu,Zn-Superoxide dismutase and its Metallochaperone, CCS, localize to the intermembrane space of mitochondria. J Biol Chem. 2001;276(41):38084\u20139.","journal-title":"J Biol Chem"},{"issue":"4","key":"391_CR40","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1006\/jmbi.1999.2807","volume":"289","author":"GA Ziegler","year":"1999","unstructured":"Ziegler GA, Vonrhein C, Hanukoglu I, Schulz GE. The structure of adrenodoxin reductase of mitochondrial P 450 systems: electron transfer for steroid biosynthesis. J Mol Biol. 1999;289(4):981\u201390.","journal-title":"J Mol Biol"},{"issue":"2","key":"391_CR41","first-page":"484","volume":"1823","author":"Y Shi","year":"2012","unstructured":"Shi Y, Ghosh M, Kovtunovych G, Crooks DR, Rouault TA. Both human ferredoxins 1 and 2 and ferredoxin reductase are important for iron-sulfur cluster biogenesis. Biochimica et biophysica acta (BBA) -. Mol Cell Res. 2012;1823(2):484\u201392.","journal-title":"Mol Cell Res"},{"issue":"31","key":"391_CR42","doi-asserted-by":"publisher","first-page":"12754","DOI":"10.1074\/jbc.R117.787101","volume":"292","author":"JJ Braymer","year":"2017","unstructured":"Braymer JJ, Lill R. Iron\u2013sulfur cluster biogenesis and trafficking in mitochondria. J Biol Chem. 2017;292(31):12754\u201363.","journal-title":"J Biol Chem"},{"issue":"3","key":"391_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41419-019-1414-7","volume":"10","author":"T Druck","year":"2019","unstructured":"Druck T, Cheung DG, Park D, Trapasso F, Pichiorri F, Gaspari M, et al. Fhit\u2013Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells. Cell Death Dis. 2019;10(3):147.","journal-title":"Cell Death Dis"},{"key":"391_CR44","unstructured":"Voet D, Voet JG, Pratt CW. Fundamentals of biochemistry: life at the molecular level. 5th edition. ed. Hoboken, NJ: John Wiley & Sons; 2016. xviii, 1098, 21, 36 pages p."},{"issue":"2","key":"391_CR45","doi-asserted-by":"publisher","first-page":"315","DOI":"10.36660\/abc.20190437","volume":"116","author":"Z Wang","year":"2021","unstructured":"Wang Z, Gao J, Teng H, Peng J. Os Efeitos Da doxorrubicina Na Bioss\u00edntese e no metabolismo do Heme Em Cardiomi\u00f3citos. Arquivos Brasileiros De Cardiologia. 2021;116(2):315\u201322.","journal-title":"Arquivos Brasileiros De Cardiologia"},{"issue":"18","key":"391_CR46","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.jacc.2013.02.012","volume":"61","author":"A Khechaduri","year":"2013","unstructured":"Khechaduri A, Bayeva M, Chang H-C, Ardehali H. Heme levels are increased in human failing hearts. J Am Coll Cardiol. 2013;61(18):1884\u201393.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"391_CR47","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/cdd.2012.105","volume":"19","author":"AJ Garc\u00eda-S\u00e1ez","year":"2012","unstructured":"Garc\u00eda-S\u00e1ez AJ. The secrets of the Bcl-2 family. Cell Death Differ. 2012;19(11):1733\u201340.","journal-title":"Cell Death Differ"},{"issue":"1","key":"391_CR48","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.immunol.16.1.395","volume":"16","author":"DT Chao","year":"1998","unstructured":"Chao DT, Korsmeyer SJ. BCL-2 FAMILY: regulators of cell death. Annu Rev Immunol. 1998;16(1):395\u2013419.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"391_CR49","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/cdd.2013.139","volume":"21","author":"D Westphal","year":"2013","unstructured":"Westphal D, Kluck RM, Dewson G. Building blocks of the apoptotic pore: how Bax and bak are activated and oligomerize during apoptosis. Cell Death Differ. 2013;21(2):196\u2013205.","journal-title":"Cell Death Differ"},{"key":"391_CR50","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2147\/CMAR.S154608","volume":"10","author":"B Kulsoom","year":"2018","unstructured":"Kulsoom B, Shamsi TS, Afsar N, Memon Z, Ahmed N, Hasnain SN, Bax. Bcl-2, and Bax\/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy? Cancer Manage Res. 2018;10:403\u201316.","journal-title":"Cancer Manage Res"},{"issue":"1","key":"391_CR51","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/sj.cdd.4400453","volume":"6","author":"H Perlman","year":"1999","unstructured":"Perlman H, Zhang X, Chen MW, Walsh K, Buttyan R. An elevated bax\/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis. Cell Death Differ. 1999;6(1):48\u201354.","journal-title":"Cell Death Differ"},{"issue":"8","key":"391_CR52","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/sj.emboj.7600592","volume":"24","author":"M Germain","year":"2005","unstructured":"Germain M, Mathai JP, McBride HM, Shore GC. Endoplasmic reticulum BIK initiates DRP1-regulated remodelling of mitochondrial Cristae during apoptosis. EMBO J. 2005;24(8):1546\u201356.","journal-title":"EMBO J"},{"issue":"S1","key":"391_CR53","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1038\/onc.2009.40","volume":"27","author":"G Chinnadurai","year":"2009","unstructured":"Chinnadurai G, Vijayalingam S, Rashmi R. BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes. Oncogene. 2009;27(S1):S20\u20139.","journal-title":"Oncogene"},{"issue":"6","key":"391_CR54","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/cdd.2013.10","volume":"20","author":"N Echeverry","year":"2013","unstructured":"Echeverry N, Bachmann D, Ke F, Strasser A, Simon HU, Kaufmann T. Intracellular localization of the BCL-2 family member BOK and functional implications. Cell Death Differ. 2013;20(6):785\u201399.","journal-title":"Cell Death Differ"},{"issue":"2","key":"391_CR55","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2016.02.026","volume":"165","author":"F Llambi","year":"2016","unstructured":"Llambi F, Wang Y-M, Victor B, Yang M, Schneider Desiree M, Gingras S, et al. BOK is a Non-canonical BCL-2 family effector of apoptosis regulated by ER-Associated degradation. Cell. 2016;165(2):421\u201333.","journal-title":"Cell"},{"key":"391_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2020.574338","volume":"8","author":"S Naim","year":"2020","unstructured":"Naim S, Kaufmann T. The multifaceted roles of the BCL-2 family member BOK. Front Cell Dev Biology. 2020;8:1\u201313.","journal-title":"Front Cell Dev Biology"},{"key":"391_CR57","doi-asserted-by":"crossref","unstructured":"Carpio MA, Michaud M, Zhou W, Fisher JK, Walensky LD, Katz SG. BCL-2 family member BOK promotes apoptosis in response to endoplasmic reticulum stress. Proceedings of the National Academy of Sciences. 2015;112(23):7201-6.","DOI":"10.1073\/pnas.1421063112"},{"issue":"4","key":"391_CR58","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s10495-008-0190-0","volume":"13","author":"S Rosebeck","year":"2008","unstructured":"Rosebeck S, Leaman DW. Mitochondrial localization and pro-apoptotic effects of the interferon-inducible protein ISG12a. Apoptosis. 2008;13(4):562\u201372.","journal-title":"Apoptosis"},{"issue":"2","key":"391_CR59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/cbi3.10009","volume":"20","author":"E Makovitzki-Avraham","year":"2013","unstructured":"Makovitzki-Avraham E, Daniel-Carmi V, Alteber Z, Farago M, Tzehoval E, Eisenbach L. The human ISG12a gene is a novel caspase dependent and p53 independent pro-apoptotic gene, that is overexpressed in breast cancer. Cell Biol Int Rep. 2013;20(2):37\u201346.","journal-title":"Cell Biol Int Rep"},{"issue":"11","key":"391_CR60","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/s41423-020-00549-9","volume":"17","author":"R Deng","year":"2020","unstructured":"Deng R, Zuo C, Li Y, Xue B, Xun Z, Guo Y, et al. The innate immune effector ISG12a promotes cancer immunity by suppressing the canonical Wnt\/\u03b2-catenin signaling pathway. Cell Mol Immunol. 2020;17(11):1163\u201379.","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"391_CR61","doi-asserted-by":"publisher","first-page":"e2025022118","DOI":"10.1073\/pnas.2025022118","volume":"118","author":"Y Toyama","year":"2021","unstructured":"Toyama Y, Harkness RW, Lee TYT, Maynes JT, Kay LE. Oligomeric assembly regulating mitochondrial HtrA2 function as examined by methyl-TROSY NMR. Proc Natl Acad Sci. 2021;118(11):e2025022118\u20131.","journal-title":"Proc Natl Acad Sci"},{"key":"391_CR62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.abb.2017.04.004","volume":"621","author":"D Zurawa-Janicka","year":"2017","unstructured":"Zurawa-Janicka D, Wenta T, Jarzab M, Skorko-Glonek J, Glaza P, Gieldon A, et al. Structural insights into the activation mechanisms of human HtrA Serine proteases. Arch Biochem Biophys. 2017;621:6\u201323.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"391_CR63","doi-asserted-by":"publisher","first-page":"37927","DOI":"10.1038\/srep37927","volume":"6","author":"K Wang","year":"2016","unstructured":"Wang K, Yuan Y, Liu X, Lau WB, Zuo L, Wang X, et al. Cardiac specific overexpression of mitochondrial Omi\/HtrA2 induces myocardial apoptosis and cardiac dysfunction. Sci Rep. 2016;6(1):37927.","journal-title":"Sci Rep"},{"key":"391_CR64","doi-asserted-by":"crossref","unstructured":"Sheeran FL, Pepe S. Mitochondrial bioenergetics and dysfunction in failing Heart. Mitochondrial dynamics in cardiovascular medicine. Advances in experimental medicine and biology2017. pp. 65\u201380.","DOI":"10.1007\/978-3-319-55330-6_4"},{"issue":"2","key":"391_CR65","doi-asserted-by":"publisher","first-page":"E449","DOI":"10.1152\/ajpendo.00127.2016","volume":"311","author":"FL Sheeran","year":"2016","unstructured":"Sheeran FL, Pepe S. Posttranslational modifications and dysfunction of mitochondrial enzymes in human heart failure. Am J Physiology-Endocrinology Metabolism. 2016;311(2):E449\u201360.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"issue":"1","key":"391_CR66","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1186\/s12864-018-5213-9","volume":"19","author":"ME Sweet","year":"2018","unstructured":"Sweet ME, Cocciolo A, Slavov D, Jones KL, Sweet JR, Graw SL, et al. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure. BMC Genomics. 2018;19(1):812.","journal-title":"BMC Genomics"},{"issue":"2","key":"391_CR67","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1161\/CIRCULATIONAHA.120.050498","volume":"143","author":"VS Hahn","year":"2021","unstructured":"Hahn VS, Knutsdottir H, Luo X, Bedi K, Margulies KB, Haldar SM, et al. Myocardial gene expression signatures in human heart failure with preserved ejection fraction. Circulation. 2021;143(2):120\u201334.","journal-title":"Circulation"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-025-00391-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-025-00391-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-025-00391-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T15:24:35Z","timestamp":1759764275000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiooncologyjournal.biomedcentral.com\/articles\/10.1186\/s40959-025-00391-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["391"],"URL":"https:\/\/doi.org\/10.1186\/s40959-025-00391-w","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study participants were drawn from a Children\u2019s Oncology Group study COG-ALTE03N1 (NCT00082745), a matched case-control study focused on understanding the pathogenesis of anthracycline-induced cardiomyopathy after childhood cancer. COG member institutions enrolled patients after obtaining approval from local Institutional Review Boards. Written informed consent or assent was obtained from patients, parents, or legal guardians. Cases and control subjects were identified from individuals diagnosed with cancer at \u2264\u200921 years of age.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent"}},{"value":"The authors declare that they have no competing interests or relationships relevant to the contents of this paper to disclose. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}